Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Revenue (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Revenue for 6 consecutive years, with $493104.0 as the latest value for Q3 2025.

  • On a quarterly basis, Revenue fell 85.58% to $493104.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.5 million, a 1.51% increase, with the full-year FY2024 number at $5.2 million, up 133.58% from a year prior.
  • Revenue was $493104.0 for Q3 2025 at Ensysce Biosciences, down from $1.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.4 million in Q3 2024 to a low of $181797.0 in Q2 2024.
  • A 5-year average of $877865.7 and a median of $515032.0 in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: soared 897.3% in 2021, then tumbled 85.58% in 2025.
  • Ensysce Biosciences' Revenue stood at $1.6 million in 2021, then decreased by 12.34% to $1.4 million in 2022, then tumbled by 64.07% to $515032.0 in 2023, then skyrocketed by 153.12% to $1.3 million in 2024, then tumbled by 62.18% to $493104.0 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Revenue are $493104.0 (Q3 2025), $1.4 million (Q2 2025), and $1.3 million (Q1 2025).